American College Of Rheumatology

Patients receiving long-term glucocorticoids should use oral bisphosphonates to reduce the risk for bone loss and fracture, according to new guidelines currently under peer review from the American College of Rheumatology.

New York is the best state for patients with rheumatic diseases to live in, while Wyoming was ranked worst in the United States, according to a new report released by the American College of Rheumatology.

While praising CMS’ 2023 Medicare Physician Fee Schedule for offering more flexibility, the American College of Rheumatology has submitted comments of concern over proposed reimbursement cuts to critical rheumatology services.

Addressing predatory copay schemes, the influence of pharmacy benefit managers and the ongoing rheumatology workforce shortage are currently among the top legislative priorities for officials at the American College of Rheumatology.

Infants who have been exposed to tumor necrosis factor inhibitors in utero should receive the rotavirus vaccine in the first 6 months of life, according to new recommendations from the American College of Rheumatology.

The Federal Trade Commission has voted unanimously to launch an inquiry into pharmacy benefit managers, requiring the six largest managers to supply records pertaining to their business practices, according to an agency press release.

The key to better understanding the efficacy vs. effectiveness gap in drug therapies could lie in real-world data and patient registries, according to a speaker at the FDA & American College of Rheumatology Virtual Summit.

Joint replacement in patients with inflammatory arthritis is often beset with pitfalls like disease flares and infectious complications, and up until recently, the emergence new treatments were rendering the current guidelines outdated.

The diagnosis, treatment, and long-term monitoring of patients with autoinflammatory type 1 interferonopathies require a multidisciplinary approach, according to joint guidelines released by EULAR and the American College of Rheumatology.

Although immune-based therapies have penetrated many medical specialties, including rheumatology, some experts have expressed concerns about the labeling of these approaches, particularly regarding immunogenicity.